ConductScience.org, home

Paper2949064

Suppressor cell function in solid tumor cancer patients.

Von Roenn J and 2 others. J Clin Oncol, 1987. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Suppressor cell function in solid tumor cancer patients. Papers, record 2949064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2949064

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Suppressor cell function in solid tumor cancer patients.
PubMed
Journal
J Clin Oncol
PubMed
Year
1987
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2017-02-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Von Roenn JJ
2Harris JEJ E
3Braun DPD P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
T-Lymphocytes, RegulatoryMajor topic
Antigens, Neoplasm
Humans
Immunocompetence
Killer Cells, Natural
Leukocyte Count
Monocytes
T-Lymphocytes

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
25381063Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).J Cancer Res Clin Oncol2015https://conductscience.org/library/papers/25381063PubMed
25196601Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies.Int J Mol Sci2014https://conductscience.org/library/papers/25196601PubMed
22674056Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.Cancer Immunol Immunother2012https://conductscience.org/library/papers/22674056PubMed
10618685The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.Med Oncol1999https://conductscience.org/library/papers/10618685PubMed
8740979Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.Urol Res1996https://conductscience.org/library/papers/8740979PubMed
2784355The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2784355PubMed
2513993
Modulation of in vitro antitumor immunity in response to the biological activators interleukin-2, gamma interferon, and granulocyte monocyte-colony stimulating factor in the peripheral blood of cancer patients receiving cytotoxic chemotherapy.
Bull N Y Acad Med1989https://conductscience.org/library/papers/2513993PubMed
1903673Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1903673PubMed
1878895Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?Cancer Immunol Immunother1991https://conductscience.org/library/papers/1878895PubMed
1684737Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1684737PubMed
1395099
Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.
Clin Exp Immunol1992https://conductscience.org/library/papers/1395099PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2949064

GET https://conductscience.org/api/papers/v1/2949064/authors